CL
CELLECT offers a non-invasive screening method for HPV and cervical cancer using a menstrual blood sample collected via tampon or pad. Their technology extracts and stabilizes DNA for compatibility with existing diagnostic tests, providing a more comfortable, accessible, and cost-effective alternative to traditional Pap smears.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- CELLECT offers a non-invasive screening method for HPV and cervical cancer using a menstrual blood sample collected via tampon or pad. Their technology extracts and stabilizes DNA for compatibility with existing diagnostic tests, providing a more comfortable, accessible, and cost-effective alternative to traditional Pap smears.